UPDATE : Friday, July 10, 2020
상단여백
‘Keytruda alone works as first-line therapy for lung cancer’ by Kim Yun-mi 2020-04-29 11:40
‘Pexa-Vec with immunotherapy reduced tumor in 75% of kidney cancer patients’ by Jeong Sae-im 2020-04-28 17:35
Genexine’s cervical cancer DNA vaccine boosts Keytruda’s response rate by Jeong Sae-im 2020-04-28 14:48
Researchers start testing pancreatitis drug to fight Covid-19 by Kim Yun-mi 2020-04-28 11:22
Genexine to present test results at US cancer academy by Shim Hyun-tai 2020-04-27 16:14
라인
‘Parasiticide showed antiviral effect as potential Covid-19 drug’ by Jeong Sae-im 2020-04-24 12:27
French envoy visits Pasteur Korea to watch Covid-19 research by Jeong Sae-im 2020-04-23 17:13
Multinational drugmakers donated ₩30 billion last year by Kim Yun-mi 2020-04-23 15:09
4 drugs recorded two-digit sales growth in Q1 despite Covid-19 by Jeong Sae-im 2020-04-23 12:18
Medytox’s faking data unpunishable due to expired statute of limitations by Jeong Sae-im 2020-04-22 11:28
라인
Abclon derives clinical materials for CAR-T treatment of ovarian cancer by Shim Hyun-tai 2020-04-21 17:49
Multidisciplinary cure is mainstream cancer treatment but cumbersome by Park Gi-taek 2020-04-21 17:09
Whistleblowers, shareholders furious over Medytox’s rebuttal by Jeong Sae-im 2020-04-21 15:19
ImmuneMed confident of drug candidate’s effect on Covid-19 by Jeong Sae-im 2020-04-21 13:23
Medytox files suit to cancel administrative order by Shim Hyun-tai 2020-04-20 16:37
라인
DM Bio signs CDMO contract with Abion for antibody treatment by Shim Hyun-tai 2020-04-17 16:03
Medytox CEO charged with making, selling botulinum toxin illegally by Jeong Sae-im 2020-04-17 16:00
Researchers to test asthma drug to treat Covid-19 by Kim Yun-mi 2020-04-16 16:20
Bukwang to test its antiviral drug against Covid-19 by Jeong Sae-im 2020-04-16 12:20
Opdivo’s indication expanded to esophageal squamous cell carcinoma by Kim Yun-mi 2020-04-16 10:48
-12345678910-
WUH’s affiliate firm exports mobile CT for Covid-19 to IranWUH’s affiliate firm exports mobile CT for Covid-19 to Iran
여백
Most viewed
여백
Opinion
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
[Reporter's Notebook] Drugmakers introduce creative PR formats amid Covid-19
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Reporter's Notebook] Korean firms found something missing in ‘virtual’ ASCO 2020
[Column] 'New normal' of healthcare in post-corona era
[Column] 'New normal' of healthcare in post-corona era
여백
Back to Top